Both synthesized nanoparticles had optimal biocompatibility with the Neuro2a neuroblastoma cell line. Additionally, both nanoparticles served a synergistic effect to prevent tau accumulation and inhibit tau aggregation. The gene discussed is MAPT; the disease is neuroblastoma.